Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aminoglycoside Administration in Septic Patients

NCT06226441 is registered in ClinicalTrials.gov with University of Thessaly as lead sponsor.

NCT NCT06226441
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06226441 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aminoglycoside Administration in Septic Patients
Lead sponsor
University of Thessaly
Phase
Not applicable
Overall status
Recruiting
Start date
June 2, 2023
Completion date
December 31, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aminoglycoside toxicity, renal replacement therapy, sepsis, septic shock